BlueRock Therapeutics – Pretty good overall, but was told to expect an update within a certain timeframe which came and went. The breakdown in communication was the only downside
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
читать еще
Эта компания принимает отзывы от проверенных сотрудников
Pretty good overall, but was told to expect an update within a certain timeframe which came and went. The breakdown in communication was the only downside